These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 135476)

  • 21. MMP-2 in the left rat ventricle is increased by growth hormone.
    Brüel A; Nyengaard JR; Danielsen CC
    Growth Horm IGF Res; 2006 Jun; 16(3):193-201. PubMed ID: 16815061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regression of cardiomegaly induced in newborn rats.
    Rakusan K; Korecky B
    Can J Cardiol; 1985; 1(3):217-22. PubMed ID: 2413972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of growth hormone on myocardial weight and water fraction in rats.
    Powis RL
    Recent Adv Stud Cardiac Struct Metab; 1975; 8():427-36. PubMed ID: 129837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroxine influences on contractile proteins from atrial and ventricular myocardium.
    Syrový I
    Physiol Bohemoslov; 1986; 35(6):491-6. PubMed ID: 2950533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes.
    Candido R; Forbes JM; Thomas MC; Thallas V; Dean RG; Burns WC; Tikellis C; Ritchie RH; Twigg SM; Cooper ME; Burrell LM
    Circ Res; 2003 Apr; 92(7):785-92. PubMed ID: 12623881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time course alterations of myocardial endothelin-1 production during the formation of exercise training-induced cardiac hypertrophy.
    Iemitsu M; Maeda S; Otsuki T; Goto K; Miyauchi T
    Exp Biol Med (Maywood); 2006 Jun; 231(6):871-5. PubMed ID: 16741015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genistein prevents isoproterenol-induced cardiac hypertrophy in rats.
    Maulik SK; Prabhakar P; Dinda AK; Seth S
    Can J Physiol Pharmacol; 2012 Aug; 90(8):1117-25. PubMed ID: 22808991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early ultrastructural changes in the myocardium following thyroxine-induced hypertrophy.
    Craft-Cormney C; Hansen JT
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1980; 33(3):267-73. PubMed ID: 6110274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of collagen type I gene expression in the ventricular myocardium of thyroidectomized male and female rats.
    Klein LE; Sigel AV; Douglas JA; Eghbali-Webb M
    J Mol Cell Cardiol; 1996 Jan; 28(1):33-42. PubMed ID: 8745212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional changes in ornithine decarboxylase activity and polyamine levels during thyroxine-induced cardiac hypertrophy.
    Tipnis UR; Skiera C
    Cytobios; 1989; 57(229):101-8. PubMed ID: 2528442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on protein metabolism in rats with right ventricular hypertrophy.
    Tanaka K; Honda M; Kuramochi T; Hashimoto M; Masumura S; Mansoor AM; Ishikawa S; Morioka S
    J Hypertens; 1994 Oct; 12(10):1147-54. PubMed ID: 7836730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional myosin heavy chain expression in volume and pressure overload induced cardiac hypertrophy.
    Dool JS; Mak AS; Friberg P; Wahlander H; Hawrylechko A; Adams MA
    Acta Physiol Scand; 1995 Dec; 155(4):396-404. PubMed ID: 8719259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac architectural changes with hypertrophy induced by excess growth hormone in rats.
    Lei LQ; Rubin SA; Fishbein MC
    Lab Invest; 1988 Sep; 59(3):357-62. PubMed ID: 2970563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased collagen mRNA and regression of cardiac fibrosis in the ventricular myocardium of the tight skin mouse following thyroid hormone treatment.
    Yao J; Eghbali M
    Cardiovasc Res; 1992 Jun; 26(6):603-7. PubMed ID: 1451140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early cardiac hypertrophy induced by thyroxine is accompanied by an increase in VEGF-A expression but not by an increase in capillary density.
    Anjos-Ramos L; Carneiro-Ramos MS; Diniz GP; Martins-Silva J; Barreto-Chaves ML
    Virchows Arch; 2006 Apr; 448(4):472-9. PubMed ID: 16440199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and regression of exercise-induced cardiac hypertrophy in rats.
    Hickson RC; Hammons GT; Holoszy JO
    Am J Physiol; 1979 Feb; 236(2):H268-72. PubMed ID: 217279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical aspects of salt-induced, pressure-independent left ventricular hypertrophy in rats.
    Kihara M; Utagawa N; Mano M; Nara Y; Horie R; Yamori Y
    Heart Vessels; 1985 Nov; 1(4):212-5. PubMed ID: 2937765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroxine-induced cardiac hypertrophy: time course of development and inhibition by propranolol.
    Klein I
    Endocrinology; 1988 Jul; 123(1):203-10. PubMed ID: 2968237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin treatment modulates collagen metabolism in isoproterenol induced myocardial necrosis in rats.
    Nirmala C; Anand S; Puvanakrishnan R
    Mol Cell Biochem; 1999 Jul; 197(1-2):31-7. PubMed ID: 10485321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression of myocardial hypertrophy. I. Experimental model, changes in heart weight, nucleic acids and collagen.
    Cutilletta AF; Dowell RT; Rudnik M; Arcilla RA; Zak R
    J Mol Cell Cardiol; 1975 Oct; 7(10):761-80. PubMed ID: 128635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.